Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed May 6, 2020 · 10-Q · 36 days after period end · 0001069530-20-000032
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$1.15M | -$1.36M | -$2.16M | -$2.74M |
| EPS Diluted | -$0.05 | -$0.08 | -$0.33 | -$0.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 6, 2020 · 36 d after period end
